The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

There is a tendency to overlook the multiple factors and stakeholders that contributed to the Rx opioid crisis. This includes ...

The Federal Trade Commission in October brought its  long-anticipated  lawsuit against the nation’s three biggest ...

Walgreens Boots Alliance has a storied history in Chicago, starting with a single retail outlet in 1901, and expanding across ...

NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...

Lindsay Bealor Greenleaf, JD, MBA, of ADVI Health, weighs in on what to expect in key health care policy areas in the wake of ...

Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...

The US trade group Pharmaceutical Research and Manufacturers of America (PhRMA) today launched new advertisements urging ...

Pharmacists across Iowa continue to voice concern over more pharmacy closures in the state and country, but pharmacy students ...

Two important bills in the U.S. Senate would bring reform to these big companies — known as Pharmacy Benefit Managers (PBMs) — and greatly lessen their detrimental impact on the wallets of American ...

Pennsylvania State Grange. Matthew Espenshade is president of the Pennsylvania State Grange.

The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.